Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marilyn S. Davis"'
Autor:
Muzaffar H. Qazilbash, Partow Kebriaei, Richard E. Champlin, Uday R. Popat, Elizabeth J. Shpall, Martin Korbling, John McMannis, Sergio Giralt, Chitra Hosing, Marilyn S. Davis, Paolo Anderlini
Publikováno v:
British journal of haematology. 133(5)
High-dose chemotherapy and autologous peripheral blood progenitor cell transplantation is an effective treatment for multiple myeloma. Progenitor cells are generally mobilised into the peripheral blood by administration of filgrastim. Pegfilgrastim i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1722084fab5b5c50e54d56bdb30277a
https://pubmed.ncbi.nlm.nih.gov/16681642
https://pubmed.ncbi.nlm.nih.gov/16681642
Autor:
Donna Przepiorka, H. Fischer, Susan Escudier, Jaroslaw Koberda, James Gajewski, Marilyn S. Davis, Issa F. Khouri, D. Seong, Huibert M. Vriesendorp, Ka Wah Chan, Yang O. Huh, Cindy Ippoliti, Richard E. Champlin
Publikováno v:
Transplantation. 58:858-860
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ebdb98c60fa20a0fff333b74956a9d4
https://doi.org/10.1097/00007890-199410000-00022
https://doi.org/10.1097/00007890-199410000-00022
Autor:
James Gajewski, Ira Braunschweig, J. Bruton, Jeffrey J. Molldrem, Borje S. Andersson, Donna Przepiorka, Issa F. Khouri, Paolo Anderlini, Cindy Ippolitti, David F. Claxton, Michele L. Donato, Xuemei Wang, A. Cohen, Steven M. Kornblau, Sergio Giralt, Michael Andreeff, Marilyn S. Davis, Peter F. Thall, Naoto T. Ueno, Richard E. Champlin
Publikováno v:
Blood. 97(3)
A reduced-intensity preparative regimen consisting of melphalan and a purine analog was evaluated for allogeneic transplantation in 86 patients who had a variety of hematologic malignancies and were considered poor candidates for conventional myeloab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3902b8e28c63e9818229307bfa1bf287
https://pubmed.ncbi.nlm.nih.gov/11157478
https://pubmed.ncbi.nlm.nih.gov/11157478
Autor:
Roy B. Jones, Richard E. Champlin, Daniel R. Couriel, Amin M. Alousi, Muzaffar H. Qazilbash, Steven G. Matthes, Rima M. Saliba, Floralyn Mendoza, Marcos de Lima, Sergio Giralt, Chitra Hosing, Marilyn S. Davis, Donna M. Weber, Partow Kebriaei, Michael Wang
Publikováno v:
Blood. 108:3090-3090
Backround: Arsenic trioxide (ATO) has been shown to be synergistic with melphalan both in vitro and in vivo. We conducted a phase I/II trial to determine the safety and efficacy of a combination of arsenic trioxide, melphalan and ascorbic acid (AA) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b94475ba094d795bd256c66fa2ae6a17
https://doi.org/10.1182/blood.v108.11.3090.3090
https://doi.org/10.1182/blood.v108.11.3090.3090
Autor:
F.R. Libunao, Linda Roden, M.H. Qazilbash, Richard E. Champlin, Sergio Giralt, Marilyn S. Davis
Publikováno v:
Biology of Blood and Marrow Transplantation. 12:165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b31cebf478654ac42638d48568c1cf
https://doi.org/10.1016/j.bbmt.2005.11.516
https://doi.org/10.1016/j.bbmt.2005.11.516
Autor:
Roy B. Jones, Peter F. Thall, Michael Wang, Donna M. Weber, Daniel R. Couriel, Xuemei Wang, Floralyn Libunao, Chitra Hosing, Linda Roden, Partow Kebriaei, Marilyn S. Davis, Aleman Ana, Steven G. Matthes, Richard E. Champlin, Muzaffar H. Qazilbash, Marcos de Lima, Sergio Giralt
Publikováno v:
Blood. 106:1159-1159
Backround: Arsenic trioxide (ATO), an active agent against multiple myeloma, has been shown to be synergistic with melphalan both in vitro and in vivo. We conducted a phase I/II trial to determine the safety and efficacy of a combination of arsenic t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48b9a10d76c1c1931cb90c802a4dcd73
https://doi.org/10.1182/blood.v106.11.1159.1159
https://doi.org/10.1182/blood.v106.11.1159.1159
Autor:
John McMannis, Beverly Rhodes, Partow Kebriaei, Sergio Giralt, Elizabeth J. Shpall, Chitra Hosing, Martin Korbling, Marilyn S. Davis, Veronica R. Smith, Muzaffar H. Qazilbash, Richard E. Champlin
Publikováno v:
Blood. 106:2923-2923
High-dose chemotherapy and autologous peripheral blood progenitor cell (APBPC) transplantation is an effective treatment for MM. Progenitor cells are generally mobilized in to the blood by administration of filgrastim alone or after chemotherapy. Sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70d8fb20f3f040010c52a523fd46c697
https://doi.org/10.1182/blood.v106.11.2923.2923
https://doi.org/10.1182/blood.v106.11.2923.2923
Autor:
Muzaffer Qazilbasch, Michele L. Donato, Michael Wang, Donna M. Weber, Marilyn S. Davis, Sergio Giralt, Ana Aleman, Floralyn Mendoza, Linda Roden, Richard E. Champlin
Publikováno v:
Blood. 106:1177-1177
Background: Topotecan at modest doses has activity in multiple myeloma (MM). The combination of high-dose topotecan, melphalan, and cyclophosphamide (TMC) has been used as a conditioning regimen for autologous SCT in patients with MM. We report the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9570ee9018f503cbb73b6b209455e066
https://doi.org/10.1182/blood.v106.11.1177.1177
https://doi.org/10.1182/blood.v106.11.1177.1177
Autor:
Xin Lei, Ana Aleman, Donna M. Weber, Marilyn S. Davis, Sergio Giralt, Michael Wang, Richard E. Champlin, Kerry Mickler
Publikováno v:
Blood. 104:1651-1651
Background: The proteosome inhibitor bortezomib (BTZ) has demonstrated significant activity against multiple myeloma (MM). In vitro data suggests that protesome inhibition has immune-modulatory activity that may be relevant in the setting of allogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28dd6f2296360b5b134bddb3d540bddf
https://doi.org/10.1182/blood.v104.11.1651.1651
https://doi.org/10.1182/blood.v104.11.1651.1651